<< Вернуться к списку статей журнала

Том 2 №1,2 2000 год - Нефрология и диализ

Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности (Обзор литературы)

Волгина Г.В.

Аннотация: Благодаря исследованиям последних лет были уточнены этиологические факторы и раскрыты многие тонкие патогенетические механизмы возникновения и прогрессирования заболеваний почек. Это способствовало внедрению в клиническую практику современных методов лечения как начальных, так и конечных стадий различных нефропатий. В то же время было отмечено изменение структуры летальности нефрологических больных, что поставило перед современной нефрологией новые задачи.

Для цитирования: Волгина Г.В. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности (Обзор литературы). Нефрология и диализ. 2000. 2(1,2):25-32. doi:

Весь текст

Ключевые слова: хроническая почечная недостаточность, кардиоваскулярные нарушения, эпидемиология, структура

Список литературы:

1. Agodoa L.Y., Eggers P.W. Renal replacement therapy in the United States: data from the United States renal data system. Amer J Kidney Dis 1995; 29: 119-133.
2. Alpert M.A., Wizemann V. Noninvasive assessment of left ventricular structure and function in patients with endstage renal disease. Contrib Nephrol 1994; 106: 13-25.
3. Alpert M.A. Cardiovascular factors influencing survival in dialysis patients. Adv Peorit Dial 1996; 112: 110-119.
4. Amann K., Wiest G., Zimmer G. et al. Redused capillary density in the myocardium of uremic rats - a stereological study. Kidney Int 1992; 42: 1079-1085.
5. Amann K., Mall G., Rits E. Myocardial intersticial fibrosis in uremia: is it relevant? Nephrol Lial Transplant 1994; 9: 127-128.
6. Аmann K., Rits E. Cardiac structure and function in renal disease. Curr Opin Nephrol Hypertens 1996; 5: 102-106.
7. Amann K., Rits E. Cardiac disease in chronic uremia: pathophysiology.Adv Ren Replace Ther 1997; 4: 212-224.
8. Amann K., Schwarz U., Torning J. et al. Some cardiac abnormalities in renal failure. In: Grunfeld J.P., Bach J.F., Kreis H. (eds). Actualites nephrologiques Jean Hamburger. Hôpital Necker 1997. Medicine-Sciences Flammarion, Paris, 1997; 1-15.
9. Barrett B.J., Parfrey P.S., Morgan J. et al. Prediction of early death in end stage renal disease patients receiving dialysis. Am J Kidney Dis. 1997; 29: 214-222.
10. Bergstrom J., Lindholm B. Malnutrition, cardiac disease and mortality: an integrated point of view. Am J Kidney Dis. 1998; 32: 834-841.
11. Bloembergen W.E., Port F.K., Mauger E.A. A comparison of cause of death between patients treate with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 184-191.
12. Bommer J. Medical complications of the long-term dialysis patients. In: Cameron S., Davison A.M., Grunfeld J.P., Kerr D., Ritz E. (eds) Oxford University, 1992; 1436-1458.
13. Bonomini V., Feletti C., Scolory M.P. et al. Atherosclerosis in uremia: a longitudial study. Am J Clin Nutr 1980; 33: 1493-1500.
14. Broun J.H., Hunt L.P., Vites N.P. et al. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9: 1136-1142.
15. Bullock R.E., Haissein A.A., Simpson I., Ward M.K. Cardiac abnormalities and exercise tolerance in patients receiving renal replecement therapy. BMJ 1984; 28: 1479-1484.
16. Burke J.F., Francos G.C., Moore L.L. et al. Accelerated atherosclerosis in chronic-dialysis patients - another look. Nephron 1978; 21: 181-185.
17. Burt R., Bupta-Burt S., Suki V.N. Reversal of left ventricular dysfunction after renal transplantation. Ann intern Med. 1989; 111: 635-640.
18. Canadian Organ Replacement Register 1993 Annual Report. Don Mills, Ontario, Canada, Canadian Institute for Health Informa-tion, 1995; 113.
19. Chakko S., Girgis I., Contreras G. et al. Effects of hemodialysis in left ventricular diastolic filling. Am J Cardiol 1997; 79: 106-108.
20. Churchill D.N., Taylor D.W., Cook R.J. et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-234.
21. Collins A., Va. J., Umen A. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23: 272-282.
22. Covic A., Goldsmith D.J.A., Clayton P., Ackrill P. Long-term hemodialysis vs renal transplantation: comparative influence on cardiac structure and function. Nephrol Dial Transplant 1994; 9: 980-981.
23. De Lima J.J.G., Abensur H., Bermardez-Silva H. et al. Role of arterial hypertention in left ventricular hypertrophy in hemodialysis patients: an echocardiographic study. Cardiology 1992; 80: 161-167.
24. De Lima J.J.G., Abensur H., Krieger E.M., Pileggi F. Arterial blood prеssure and left ventricular hypertrophy in hemodialysis patients. J Hypertens 1996; 14: 1019-1024.
25. Devereux R.B., Alonso D.R., Lutas E.M., Gotlieb G.J. et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Kidney Dis 18, 1991; Suppl 2: 1-127.
26. Devereux R.B., Koren M.J., Simone G. et al. Applicaicion to hypertensive heart disease. Eur Heart J 14, 1993; Suppl D: 8-15.
27. Disney A.P. Demografy and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: Report of dialysis and renal transplantation treatment from the Australia and New Zealand dialysis and transplant registry. Am J Kidney Dis 25:1995; 165-175.
28. Erturk S., Ertug A.E., Ates K. et al. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in hemodialysis patients. Nephrol Dial Transplant 1996; 11: 2050-2054.
29. Fearnandez J.N., Carbonell M.E., Mazzuchi N., Petruccelli D. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 1992; 41: 1029-1034.
30. Foley R.N., Parfrey P.S., Harnett J.D. et al. Clinical and echocardiographic disease in patients starting and stage renal disease therapy: prevalence, associations and prognosis. Kidney Int 1994 (in press).
31. Foley R.N., Parfrey P.S., Hefferton D. et al. Advance prediction of death in patients starting maintenance dialysis. Am J Kidney Dis 1994; 23: 836-845.
32. Foley R.N., Parfrey P.S., Harnett J.D. et al. Clinical and echocardiographic disease in end-stage renal disease: prevalence, associations and prognosis. Kidney Int 1995; 47: 186-192.
33. Foley R.N., Parfrey P.S., Harnett J.D. et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031.
34. Foley R.N., Parfrey H.S., Harnett J.D. et al. Impact of hypertension on cardiomyopathy, morbididy and mortality in end stage renal disease. Kidney Int 1996; 49: 1379-1385.
35. Foley R.N., Parfrey P.S., Harnett J.D. et al. The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis 1996; 28: 53-61.
36. Foley R.N., Parfrey P.S., Harnett J.D. et al. Hypoalbuminemia, cardiac morbidity and mortality in end stage renal disease. J Am Soc Nephrol 1996; 7: 728-736.
37. Foley R.N., Culleton B.F., Parfrey P.S. et al. Cardiac disease in diabetic end-stage renal disease. Diabetologia 1997; 40: 1307-1312.
38. Foley R.N., Parfrey P.S. Cardiac disease in chronic uremia: clinical outcome and risk factors. Adv Ren Replace Ther 1997; 4: 234-248.
39. Foley R.N., Parfrey P.S., Morgan J. et al. A randomized con-trolled trial of complete vs partial correction of anemia in hemodialysis patients with asymptomatic concentric LV hypertrophy or LV dilatation [Abstract]. J Am Soc Nephrol 1998; 9: 208A.
40. Foley R.N., Parfrey P.S., Kent G.M. et al. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998; 54: 1720-1725.
41. Foley R.N., Parfrey P.S., Sarnak M. Epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998; 32 [Suppl 3]: 12-19.
42. Foley R.N., Parfrey P.S. Cardiac function and cardiac disease in renal failure. Primer on kidney disease. Ed. A.Greenberg. Academic Press, 1998; 455-459.
43. Foley R.N., Parfrey P.S., Harnett J.D. et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998; 9: 267-276.
44. Galderisi M., Benjamin E., Evans J. Impact of heart rate and PR-interval on Doppler indexes of left ventricular diastolic filling in an elderly cohort (the Framingham heart study). Am J Cardiol 1993; 72: 1183-1187.
45. Gentil M.A., Carriazo A., Pavon M.I. et al. Comparison of survial in continuons ambulatory peritoneal dialysis and hospital hemodialysis. A multicentric study. Nephrol Dial Transplant 1991; 6: 444-451.
46. Gonsorcik I., Lzakacs M., Palco S., Mydlik M. Pharmacotherapy of silent myocardial ischemia in patients on hemodialysis. Vnutr Lek 1996; 42(12): 837-841.
47. Greaves S.C., Gamble G.D., Collins J.E. et al. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24(5): 768-776.
48. Grossman E., Shemesh J., Shamiss A. et al. Left ventricular mass in diabetes-hypertension. Arch Intern Med 1992; 152: 1001-1004.
49. Ha S.K., Park H.S., Kim S.U. et al. Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure. J Korean Med Sci 1998; 13(5), 488-494.
50. Harnett J.D., Parfrey P.S., Griffiths S.M. et al. Left ventricular hypertrophy in end-stage renal disease. Nephron 1988; 48: 107-115.
51. Harnett J.D., Parfrey P.S. The management of congestive heart failure in uremia patients. Cardiac dysfunction in chronic uremia. Eds. PS Parfrey, JD Harnett. Norwell 1992; 14: 221-229.
52. Harnett J.D., Murphy B., Collingwood P., Parfrey P.S. The reability and validity of echocardiographic measurement of left ventricular mass in hemodialysis patients. Nephron 1993; 65:212-214.
53. Harnett J.D., Kent G.M., Barre P.E. et al. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4:1486-1490.
54. Harnett J.D., Parfrey P.S. Left ventricular dysfunction in dialysis patients. Henrich WL (ed): Principles and practice of dialysis. Baltimore. MD Williams, Willkins, 1995; 170-180.
55. Harnett J.D., Foley R.N., Kent G.M. et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47:884-890.
56. Harnett J.D., Foley R.N., Kent G.M. et al. Congestive heat failure in dialysis patients: prevalence, incidence, prognosis, and risk factors. Kidney Int 1996; 49:1428-1434.
57. Held P.J., Levin N.W., Pauly M.V., Diamond L.H. Mortality and duration of hemodialysis treatment. JAMA 1991; 265:871-875.
58. Herzog C.A., Ma J.Z., Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl Med 1998; 339:799-805.
59. Huchins G.M. Cardiac pathology in chronic renal failure. Сar-diac dysfunction in chronic uremia. Eds PS Parfrey, JD Harnett. Norwell 1992; 6: 86-104.
60. Hutchinson T.A., Thomas C.D., MacGibbon B. Predicting survival in adults with end stage renal failure: an age-equivalence index. Ann Intern Med 1982; 96: 417-423.
61. Huting J., Kramer W., Reittinger J. et al. Cardiac structure and function in continuous ambulatory peritoneal dialysis: influence of blood purification and hypercirculation. Am Heart J 1990; 119: 334-352.
62. Huting J., Kramer W., Reitinger J. et al. Abnormal diastolic left ventricular filling by pulsed doppler echocardiografy in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991; 36: 21-28.
63. Huting J. Cardiac problems in end-stage renal disease: left ventricular structure and function. Primary Cardiol 1991; 17:42-56.
64. Huseyin T., Ozerkan F., Unsal A. et al. Dilated uremic cardiomyopathy in a dialysis patients cured by persistent ultrafiltration. Am J Kidney Dis 1998; 32(4):664-668.
65. Huwez F.U., Pringle S.D., Macfarlane P.W. A new classification of left ventricular geometry in patients with cardiac disease based on M-mode echocardiography. Am J Cardiol 1992; 70:681-688.
66. Ibels L.S., Stewart J.H., Mahony J.F. et al. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. Q J Med 197746:197-214.
67. Iseki K., Kawazoe N., Fukiyama K. Serum albumin in a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44:115-119.
68. Johnstone L.M., Jones C.L., Grigg L.E. et al. Left ventricular abnormalities in children, adolescent and young adults with renal disease. Kidney Int 1996; 50:998-1006.
69. Kannel W.B., Cobb J. Left ventricular hypertrophy and mor-tality - results from the Framingham study. Cardiology 1992; 81:291-298.
70. Kasiske B.L., Guijarro C., Massy Z.A. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7:158-165.
71. Keane W.F., Collins A.J. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24:1010-1018.
72. Kikert D., Mitch W. The Heart. Ed. R.C.Schlant.- New Jork 1994; 1961-1970.
73. Klahr S., Levey A.C., Beck G.I. et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. New Engl J Med 1994; 330:877-884.
74. Kong T.Q., Dacanay S., Hsich A.A. Features of acute myocardial infarction in patients on chronic hemodialysis. Circulation 1993; 88(Suppl.1):1-49.
75. Lameire N. Cardiovascular risk factors and blood pressure control in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): 394-395.
76. Lameire N., Bernaert P., Lambert M.C., Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994; 46(Suppl 48):31-38.
77. Lagagh G. Cardiac pathophysiology and its heterogeneity in patients with established hypertensive disease. Am J Med 1988; 84:3-11.
78. Levey A.S., Beto J.A., Coronado B.E. et al. Controling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998; 32:853-906.
79. Levey A.S., Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-833.
80. Levin A., Singer J., Thompson C.R., Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-354.
81. Levin A., Thompson C.R., Ethier J. et al. Left ventricular mass increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 1999, in press.
82. Lindholm A., Albechtsen D., Frodin L. et al. Ischemic heart disease: Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451-457.
83. Lindner A., Chara B., Sherrard D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. New Engl J Med 1974; 290: 697-701.
84. London G.M., Fabiani F., Marchais S.J. et al. Uremic car-diomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 1987; 31: 973-980.
85. London G.M., De Vernejoul M.C., Fabiani F. et al. Assotiation between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients. Am J Kidney Dis 1989; 13: 75-83.
86. London G.M., Marchais S.J., Guerin A.P. et al. Cardiovascular function in hemodialysis patients, in Advances in Nephrology (vol 20), edited by Grunfeld J.P., Bach J.F., Funk-Brentand J.L., Maxwell M.H., St. Louis, Mosby Year Book Publisher, 1991; 249-273.
87. London G.M., Fabiani F. Left ventricular dysfunction in end-stage renal disease: Echocardiographic insights. In: Cardiac Dysfunction in Chronic Uremia, edited by Parfrey PS, Harnett JD, Boston, Kluwer, 1992; Chapt 8; 117-138.
88. London G.M., Marchais S.J., Guerin A.P. et al. Cardiac hypertrophy and arterial alteration in ESRD: Hemodinamic factors. Kidney Int 1993; 43(suppl 41): 42-49.
89. London G.M., Pannier B., Guerin A.P. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blokade. Circulation 1994; 90: 2786-2796.
90. London G.M., Guerin A.P., Marchais S.J. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608.
91. London G., Parfrey P.S. Cardiac disease in chronic uremia: Pathogenesis. Adv Renal Replace Ther 1997; 4: 194-211.
92. Low I., Grutzmacher P., Bergmann M., Schoeppe W. Echocardiographic findings in patients on maintenance hemodialysis substitured with recombinant human erythropoetin. Clin Nephrol 1989; 31: 26-30.
93. Lubbecke F., Matthias F.R., Richer U. et al. Coronary risk factors in chronic hemodialysis patients. Med Klin 1996; 91(11): 687-693.
94. Maiorca R., Vonesh E.F., Cavalli P.L. et al. A multicenter selection adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11: 118-127.
95. Mall G., Rambausek M., Neumeister A. et al. Myocardial interstitial fibrosis in experimental uremia - implication for cardiac compliance. Kidney Int 1988; 33: 804-811.
96. Mall G., Huther W., Schneider J. et al. Diffuse intercardiomyocytic fibrosis in uremic patients. Nephrol Dial Transplant 1990; 5:39-44.
97. Manske C.L., Wilson R.F., Wang Y., Thomas W. Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 1997; 29:601-607.
98. Mimran A., Ribstein J. Antihypertensive therapy in renal disease and transplantation. J Hypertens 1992; 10(suppl):79-85.
99. Munson J.I., Bennett W.H., Barry J.M., Norman D.J. A case cont-rol study of renal transplantation in patients with type 1 diabetes. Clin Transplantation 1992; 6: 306-311.
100. Murphy S.W., Parfrey P.S. Screening for cardiovascular disease in dialysis patients. Curr Opin Nephrol Hypertens 1996; 5:532-540.
101. Murphy S., Foley R.N., Barrett B.J. et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. J Am Soc Nephrol 1998; 9: 237A.
102. Murphy S.W., Foley R.N., Parfrey P.S. Screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3):184-199.
103. National Kidney Foundation Task Force on cardiovascular disease: controlling the epidemic of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3):1-199.
104. Napoli C., Di-Gregorio F., Sorice P. et al. High prevalence of myocardial ischemia and vasoconstrictive hormonal release in hypertention during chronic renal failure. Nephron 1977; 76(4): 434-444.
105. Natsume T. Therapeutic advances in the treatment of LVH. Eur Heart J. 1993; 14:33-37.
106. Nicholls A.J., Catto G.R.D., Edward N. et al. Accelerated atherosclerosis in long-term dialysis and renal transplant patients. Fact or fiction? Lancet 1980; 1:276-278.
107. Odaha M. Mortality in chronic dialysis patients in Japan. Am J Kidney Dis 1990; 15:410-413.
108. Palmer B.F., Herrich W.L. The effect of dialysis of left ventricular contractility. Cardiac disfunction in chronic uremia. Eds.PS Parfrey, JD Harnett. Norwell,1992; Chart 11; 172-185.
109. Parfrey P.S., Harnett J.D., Griffiths S.M. et al. Congestive heart failure in dialysis patients. Arch Intern Med 1988; 148: 1519-1525.
110. Parfrey P.S., Griffits S.M., Harnett J.D. et al. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Amer J Nephrol 1990; 10: 213-221.
111. Parfrey P.S., Harnett J.D., Griffits S.M. et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55:114-120.
112. Parfrey P.S. Cardiac and cerebrovascular disease in chronic uremia. Amer J Kidney Dis 1993; 21:77-80.
113. Parfrey P.S., Harnett J.D., Foley R.N. Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens 1995; 4: 105-110.
114. Parfrey P.S., Harnett J.D., Foley R.N. et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995; 60: 908-914.
115. Parfrey P.S., Foley R.N., Harnett J.D. et al. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49:1428-1434.
116. Parfrey P.S., Foley R.N., Harnett J.D. et al. The outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996; 11:1277-1285.
117. Parfrey P.S., Foley R.N. The clinic epidemiology of cardiac disease in chronic renal failure. J Amer Soc Nephrol 1997; 10:1-18.
118. Parfrey P.S. (editor): Cardiac disease in chronic uremia: Uremia-related risk factors. Semin Dial 1999; 12: 1-132.
119. Portoles J., Torralbo A., Martin P. et al. Cardiovascular effects of recombinant human erytropoietin in predialysis patients. Am J Kidney Dis 1997; 29: 541-548.
120. Prevention of coronary heart disease in clinical practice: recomendation of the task force of the European Society of Cardiology. European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-1331.
121. Raine A.E.G., Margreiter R., Brunner F.P. et al. Report on management of renal failure in Europe, XX11,1991. Nephrol Dial Transplant 1992; 7(suppl 2): 7-35.
122. Ritz E., Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993; 21 (suppl 2): 113-118.
123. Ritz E., Deppisch R., Stier E., Hansch G. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 1994; 9(suppl 2): 165-172.
124. Roig E., Betrin A., Castaber A. Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysis. Am J Med 1981; 71: 431-434.
125. Rossi M.A., Carillo S.V. Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena? Int J Cardiol 1991; 31: 133-142.
126. Rostand S.G., Rutsky E.A. Ischemic heart disease in chronic renal failure: demography, epidemiology and pathogenesis. Cardi-ac dysfunction in chronic uremia. Eds. PS Parfrey, JD Parfrey, JD Harnett. Norwell 1992; 4: 54-66.
127. Rubin T.A., Thielen K.A., Collins A.L., Herzog C.A. Acute myocardial infarction in chronic dialysis patients. J Am Coll Cardiol 1996; 27: 67A(abstract).
128. Sadler D.B., Brown J., Nurse H., Roberts J. Impact of hemodialysis on left and right ventricular Doppler diastolic filling indices. Am J Med Sci 1992; 304: 83-90.
129. Sharpe N. Cardiac remodelling in congestive heart failure. Congestive heart failure. Pathophysiology, diagnosis and comprehesive approach to management. New Jork - Budapest 1994; 6: 83-94.
130. Silberberg J.S., Rahal D.P., Patton R., Sniderman A.D. Role of anemia in the pathogenesis of LVH in ESRD. Am J Cardiol 1989; 64: 222-224.
131. Silberberg J.S., Barre P.E., Prichard S.S. et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290.
132. Straumann E., Bertel O., Meyer B. et al. Symmetric and asymmetric left ventricular hypertrophy in patients with end-stage renal failure on long-term hemodialysis. Clin Cardiol 1998; 21(9): 672-678.
133. Takeda K., Nakamoto M., Baba M. et al. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Clin Nephrol 1998; 49: 308-312.
134. Teraoka S., Toma H., Nihei H. et al. Current status of renal replacement therapy in Japan. Amer J Kidney Dis 1995; 25: 151-164.
135. Thuraisingham R.C., Tucker B., Lipkin G.W. et al. Left ventricular hypertrophy in early renal failure. Nephrol Dial Transplant 1994; 7: 859-860.
136. Tschope W., Koch M., Thomas B., Ritz E., and German Study Group Diabetes and Uremia. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis: Results of a prospective study. Nephron 1993; 64: 354-358.
137. U.S. Renal Data System: USRDS 1998 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April 1998.
138. Valsania P., Sarich S.W., Kowalchuk G.J. Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. Am Heart J 1991; 122: 695-700.
139. Van Hoevan K.H., Factor S.M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease circulation. Circulation 1999; 82: 848-855.
140. Viglino G., Cancarini G., Catizone L. et al. Ten years of con-tinuous ambulatory peritoneal dialysis: Analysis of patients and technique survival. Perit Dial Bull 1993; 13(suppl 2):175-179.
141. West M., Sutherland D.E., Matas A.J. Kidney transplant recipients who die with functioning grafts, serum creatinine level and cause of death. Transplantation 1996; 62: 1029-1031.
142. Wizemann V., Timio M., Alpert M.A., Kramer W. Options in dialysis therapy: significance of cardiovascular finding. Kidney Int 1993; 43: 85-91.
143. World Health Statistics Annual 1998; 196.
144. Young E.W., Carroll L.E., Wolfe R.A. Trends in comorbidity and residual renal function in patients starting treatment for end-stage renal disease (Abstract). J Am Soc Nephrol 1995; 6: 569A.

Другие статьи по теме

• Распространенность и структура заболеваний почек у пациентов по данным амбулаторно-поликлинического приема
• Диастолическая дисфункция у больных с хронической почечной недостаточностью
• Артериальная гипертензия и почки (По материалам 9-й Европейской конференции по кардионефрологии, Ассиси, Италия, 11-13 апреля 2002 года)
• Хроническая почечная недостаточность (хроническая болезнь почек 3-5 стадии) у детей Воронежского региона